JENOPTIK AG - Nine months 2021

Dr. Stefan Traeger I Hans-Dieter Schumacher | November 10, 2021

© Copyright Jenoptik. All rights reserved.

Disclaimer

This presentation can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the development or the performance of the company to be materially different from the announced forward-looking statements. Such factors can be, among others, pandemic diseases, changes in currency exchange rates and interest rates, the introduction of competing products or the change of the business strategy. The company does not assume any obligation to update such forward-looking statements in this document in the light of future developments.

10/11/2021

Nine months 2021

2

Highlights

Highlights: Acquisition of Berliner Glas Medical and SwissOptic; record EBITDA as well as high order intake and revenue in the first nine months of 2021

Nine months 2021

  • Strengthening of the global and fast-growing photonics business through acquisition of Berliner Glas Medical and SwissOptic
  • Strong order intake of 761.0 million euros due to continued high demand (plus 49.0% compared with prior year)
  • At 609.2 million euros revenue clearly exceeded prior-year level
  • Profitability remained at very high level (EBITDA margin 19.9%) due to very good operating performance and one-off effects

Fiscal year 2021

  • Guidance for fiscal year 2021 confirmed
  • On track to meet
    our increased guidance for 2021
  • Acquisition accelerates growth and stronger focus on photonics

10/11/2021

Nine months 2021

4

Strengthening global photonics business

Jenoptik to acquire Berliner Glas Medical and SwissOptic:

  • Accelerated growth and stronger focus on photonics
  • Expansion of global presence in attractive markets (semicon, medical)
  • Broadening of customer and product portfolio

10/11/2021

Nine months 2021

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Jenoptik AG published this content on 10 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 November 2021 06:44:18 UTC.